Dexcom G7 Continuous Glucose Monitoring System recall: Sensors identified as scrap were diverted and sold by third-party
Sensors identified as scrap were diverted and sold by third-party
The hazard: Device safety concern
A device recall was filed for this product. For anything implanted or relied on daily, the clinician comes before the paperwork.
What the notice says: Sensors identified as scrap were diverted and sold by third-party
Why it matters: The FDA recorded an enforcement action against this device. Most device recalls are corrections rather than removals, so the device often stays in use while the manufacturer issues a fix.
Recall details
- Recall number
- Z-2574-2026
- Published
- May 26, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Dexcom G7
- Product type
- Medical devices
- Units affected
- N/A
- Lot / code info
- Lot Code: UDI-DI: 00386270004109 Lot Numbers: 1725204004 and 1725069002
- UPC codes
- 00386270004109
- Reports of harm
- There have been no reported severe adverse events associated with the stolen product.
Products covered by this recall
Continuous Glucose Monitoring System
What the company announced
Through ongoing quality and accounting reviews, Dexcom discovered two lots of scrapped product were stolen by a third party before destruction and sold into the market.
Dexcom is working closely with the FDA and other authorities to ensure patient safety and to investigate the crime.
SAN DIEGO – MAY 26, 2026 – DexCom, Inc. (Nasdaq: DXCM), the global leader in glucose biosensing, announced today through ongoing quality and accounting reviews it recently identified certain lots of Dexcom G7 sensors originally designated as scrap and intended for destruction were stolen during the destruction process, then sold by third parties.
Scrapping limited amounts of sensors that do not meet Dexcom standards is a routine part of the company’s quality control process. Sensors identified as scrap are sent to a third-party vendor for destruction and recycling.
At this time, Dexcom has identified two lots of Dexcom G7 sensors ( 1725204004 and 1725069002 ) that were stolen, sold and used by some customers.
“Nothing matters more to Dexcom than the safety of our users and maintaining the trust of the diabetes community,” said Jake Leach, president and CEO of Dexcom. “We are treating this matter with the utmost seriousness and are working closely with regulators and other authorities to ensure user safety, determine exactly how this product was stolen and hold the perpetrators fully accountable for their crimes.”
Dexcom traced sales of this stolen product back to Pharmsource, LLC, who is not an authorized Dexcom distributor but supplies some independent pharmacies and DME distributors in the United States. Pharmacies that purchased product from Pharmsource should take extra care to review their inventory.
Dexcom is notifying customers directly across numerous communication channels. This issue primarily impacts the US, therefore communication to US customers will precede communication to OUS customers.
Users with sensors from affected Dexcom G7 lots ( 1725204004 and 1725069002 ) should not use those sensors and can call Dexcom Customer Support in the US at 1-844-478-1600 to request replacements. More information on how to determine if sensors are from an affected lot and what action to take is available at www.dexcom.com/theft-check . Dexcom is working to update this website with resources for users outside the US and will notify those users as soon as it is updated.
Dexcom's authorized distributors provide Dexcom G7 sensors to the largest pharmacy retailers and medical distributors in the United States and around the world. Pharmacy retailers and medical distributors who receive Dexcom product from authorized Dexcom distributors are not impacted. Educational samples are also not impacted. The authorized US Dexcom distributor list can be found at www.dexcom.com/dexcom-suppliers .
Potential harm associated with stolen product.
Lot 1725204004: Dexcom G7 sensors that are not properly sterilized have an increased risk of skin infection.
Lot 1725069002: Dexcom G7 sensors from a lot with an elevated internal testing failure rate have an increased risk of having no sensor readings available.
There have been no reported severe adverse events associated with the stolen product.
About DexCom, Inc.
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.
Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com .
- Media Contact: James McIntosh · Investor Contact: Sean Christensen
- Media Contact: 959-716-6698 · Investor Contact: 858-203-6657
- Media Contact: [email protected] · Investor Contact: [email protected]
Reproduced from the company announcement posted on fda.gov. Links and contact forms in the original are not repeated here; the official notice below has them.
Check your product
The notice names 5 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
UPC / barcode
Read the twelve digits under the barcode on the package.
- 00386270004109
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- 1725204004
- 1725069002
Model or item number
On the rating label, the box or the instruction sheet.
- STP-AT-012
Package size
Match the net weight or the piece count on the front of the pack.
- 1 pack
Codes are lifted verbatim from the FDA — Company recall announcements notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Device
Dexcom G7 — A device recall was filed for this product. For anything implanted or relied on daily, the clinician comes before the paperwork.
- Match the model, catalogue, lot and serial numbers on your device against the identifiers on this page.
- If the device is implanted or you depend on it daily, speak to your clinician before changing how you use it.
- Ask the supplier or clinic that provided it what the remedy is in your case.
- If you are a facility, quarantine affected stock and log the correction.
Claiming on a recalled device
Device recalls are tracked by serial and lot number, so your claim moves faster if you lead with those.
- Have the model, catalogue, lot and serial numbers ready before you call — they are on the device label or its box.
- Ask explicitly whether your unit is in the affected range; many recalls cover only part of a model line.
- If you need the device daily, ask what interim arrangement they offer while the remedy is carried out.
- Log the date, the name and the reference number of every call. Device recalls can run for months.
Company contact: Dexcom, Inc. — Consumers: Dexcom Customer Support, 1-844-478-1600 — Media: James McIntosh, 959-716-6698, [email protected]
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Company recall announcements record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Dexcom G7 medical devices recalled?
Sensors identified as scrap were diverted and sold by third-party Sensors identified as scrap were diverted and sold by third-party
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: UPC 00386270004109; lot code 1725204004, 1725069002; model number STP-AT-012. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Match the model, catalogue, lot and serial numbers on your device against the identifiers on this page.
Can I get my money back?
Have the model, catalogue, lot and serial numbers ready before you call — they are on the device label or its box.
Related recalls
-
Class II · 8 days ago
Howmedica Osteonics Corp. TS Universal Baseplate Finishing Tray, Triathlon recall: Reprocessing instructions provided in LSTPI-B specify a sterilization dry
Reprocessing instructions provided in LSTPI-B specify a sterilization dry time of 30 minutes for the trays sterilized in blue wrap. When blue wrap is…
-
Class II · 8 days ago
Ferno-Washington Inc Power F2 Powered Fastening System, Power F2 recall: Firmware issue may result in intermittent loss or degradation of powered
Firmware issue may result in intermittent loss or degradation of powered functionality when paired with compatible stretcher. The issue may lead to…
-
Class II · 8 days ago
Howmedica Osteonics Corp. Triathlon Hinge Femoral Prep Tray recall: Reprocessing instructions provided in LSTPI-B specify a sterilization dry
Reprocessing instructions provided in LSTPI-B specify a sterilization dry time of 30 minutes for the trays sterilized in blue wrap. When blue wrap is…
-
Class II · 8 days ago
Medline surgical convenience kits labeled as: 1) Open Heart Pack A & recall: Medical convenience kits were distributed containing cannula components
Medical convenience kits were distributed containing cannula components which do not conform to ISO 80369-7 dimensional requirements and may…
-
Class I · 8 days ago
Instrumentation Laboratory HemoslL AcuStar HIT-lgG recall: Potential for invalid calibration curve or negative mean bias of up to 47%
Potential for invalid calibration curve or negative mean bias of up to 47% with patient samples.
-
Class II · 8 days ago
Cook Incorporated Williams Cystoscopic Injection Needles recall: The female Luer lock adapter component in the affected device lots
The female Luer lock adapter component in the affected device lots may not have been correctly seated due to misalignment and inadequate torquing…